Sunshine Biopharma Inc. Overview

Sunshine Biopharma, Inc., a prominent player in the biotechnology sector, is dedicated to the research, development, and commercialization of oncology and antiviral drugs, alongside science-based nutritional supplements. The company operates on a global scale, catering to a diverse customer base worldwide. Listed on the Nasdaq stock exchange, Sunshine Biopharma continues to make strides in the health care industry.

Recent Financial Performance

As of April 24, 2025, Sunshine Biopharma’s stock closed at $1.51. This figure represents a significant fluctuation over the past year, with the stock reaching a 52-week high of $23.20 on May 13, 2024, and a 52-week low of $1.169 on April 16, 2025. The company’s market capitalization currently stands at approximately $5,025,762 USD.

Company Focus and Operations

Sunshine Biopharma’s primary focus lies in the development of innovative oncology and antiviral treatments. The company also invests in the creation of science-based nutritional supplements, aiming to enhance overall health and wellness. Their global operations allow them to serve a wide range of customers, reinforcing their position in the competitive biotechnology landscape.

For more detailed information about Sunshine Biopharma’s activities and offerings, interested parties are encouraged to visit their official website at www.sunshinebiopharma.com .